A detailed history of Jpmorgan Chase & CO transactions in Nutri Band Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 12 shares of NTRB stock, worth $46. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Previous 18 33.33%
Holding current value
$46
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$3.84 - $9.25 $23 - $55
-6 Reduced 33.33%
12 $0
Q2 2024

Aug 12, 2024

BUY
$3.35 - $6.16 $20 - $36
6 Added 50.0%
18 $0
Q1 2024

May 10, 2024

BUY
$2.3 - $4.52 $6 - $13
3 Added 33.33%
12 $0
Q4 2023

Feb 12, 2024

BUY
$1.93 - $3.02 $5 - $9
3 Added 50.0%
9 $0
Q3 2023

Nov 14, 2023

BUY
$2.38 - $4.63 $14 - $27
6 New
6 $0

Others Institutions Holding NTRB

About NutriBand Inc.


  • Ticker NTRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,803,260
  • Market Cap $30.4M
  • Description
  • Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...
More about NTRB
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.